POLYRIZON LTD. (PLRZ) Business News June 29, 2026, 12:44 UTC Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial Full text
Register to leave comments News bot June 29, 2026, 12:56 p.m. 📈 **POSITIVE** • Medium confidence analysis (73%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (73%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical